GENB (Generate Biomedicines) Accounts Payable: $3.84 Mil (As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Accounts Payable?

Generate Biomedicines GENB +2.18% 6 Accounts Payable is $3.84 Mil as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Generate Biomedicines's Accounts Payable for the quarter that ended in Dec. 2025 was $3.84 Mil.

Generate Biomedicines's quarterly Accounts Payable increased from . 20 ($0.00 Mil) to Dec. 2024 ($5.67 Mil) but then declined from Dec. 2024 ($5.67 Mil) to Dec. 2025 ($3.84 Mil).

Generate Biomedicines's annual Accounts Payable increased from . 20 ($0.00 Mil) to Dec. 2024 ($5.67 Mil) but then declined from Dec. 2024 ($5.67 Mil) to Dec. 2025 ($3.84 Mil).

Generate Biomedicines Accounts Payable Related Terms

Generate Biomedicines Accounts Payable Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Accounts Payable Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Accounts Payable
5.67 3.84

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Accounts Payable 5.67 3.84
GENB
6GF Score
Generate Biomedicines Inc GENB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $3.84 Mil mean?
Generate Biomedicines (GENB) has a Accounts Payable of $3.84 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Generate Biomedicines and its competitors.
Is Generate Biomedicines' Accounts Payable too high?
Generate Biomedicines' current Accounts Payable is $3.84 Mil. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' Accounts Payable compare to PVLA and SLBT?
Generate Biomedicines' Accounts Payable of $3.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Generate Biomedicines and its competitors. Generate Biomedicines's current Accounts Payable is $3.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current Accounts Payable of $3.84 Mil. The current Accounts Payable is $3.84 Mil. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current Accounts Payable is $3.84 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price